Fractyl Health Ratios (2023-2026) | GUTS

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 40.00%34.72%30.56%71.43%42.42%44.19%50.00%100.00%
EBT Margin (Quarter) -233,800.00%-16,279.17%-37,908.33%-178,828.57%-61,951.52%-50,255.81%-163,192.86%-816,133.33%
EBIT Margin (Quarter) -242,140.00%-16,493.06%-38,536.11%-185,442.86%-65,278.79%-53,453.49%-169,957.14%-840,333.33%
EBITDA Margin (Quarter) -242,140.00%-16,493.06%-38,536.11%-185,442.86%-65,278.79%-53,453.49%-169,957.14%-840,333.33%
Operating Margin (Quarter) -242,140.00%-16,493.06%-38,536.11%-185,442.86%-65,278.79%-53,453.49%-169,957.14%-840,333.33%
Net Margin (Quarter) -323,360.00%-47,937.50%-55,772.22%-335,857.14%-15,330.30%-40,067.44%-165,521.43%-832,333.33%
FCF Margin (Quarter) -191,400.00%-16,265.28%-30,455.56%-152,414.29%-35,548.48%-46,595.35%-130,371.43%-575,566.67%
Efficiency
Inventory Average (Quarter) 0.07M0.07M0.07M0.07M
Assets Average (Quarter) 119.87M154.98M136.68M117.50M95.56M72.52M88.14M117.84M110.39M
Equity Average (Quarter) -277.96M-299.85M-316.12M-120.44M77.47M60.54M39.37M17.40M-5.92M-10.70M3.14M15.42M
Invested Capital (Quarter) -263.39M-292.52M-307.18M-325.06M84.18M70.75M50.32M28.42M6.38M-18.21M-3.18M9.46M21.38M
Asset Utilization Ratio (Quarter) 0.000.000.000.00
Leverage & Solvency
Debt to Equity (Quarter) -0.170.340.400.601.064.61-1.65-9.683.231.41
Debt Ratio (Quarter) 0.720.180.190.240.280.350.480.270.250.30
Equity Ratio (Quarter) -4.270.510.480.400.260.08-0.29-0.030.080.22
Valuation
Enterprise Value (Quarter) -33.52M-121.76M-102.75M-84.66M-67.46M-42.10M-22.30M-77.66M-81.54M-63.17M
Return Ratios
Return on Sales (Quarter) -23.38%-1.63%-3.79%-17.88%-6.20%-5.03%-16.32%-81.61%
Return on Capital Employed (Quarter) -56.54%-50.73%-67.21%-95.71%-126.04%-196.96%-142.16%-97.29%-97.78%
Return on Assets (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.00%0.00%-0.01%-0.01%-0.02%-0.05%0.16%0.09%-0.30%-0.06%